Hikma Pharmaceuticals PLC (LON:HIK)
United Kingdom flag United Kingdom · Delayed Price · Currency is GBP · Price in GBX
1,694.00
+22.00 (1.32%)
Oct 22, 2026, 4:35 PM BST

Hikma Pharmaceuticals Revenue

Hikma Pharmaceuticals had revenue of $1.73B USD in the half year ending June 30, 2026, with 10.13% growth. This brings the company's total for the last twelve months to $3.42B, up 6.31% year-over-year. In the year 2025, Hikma Pharmaceuticals had annual revenue of $3.35B with 7.10% growth. That makes Hikma Pharmaceuticals the 3,439th largest company in the world by revenue and 112th in the United Kingdom.

Revenue (ttm)
$3.42B
Revenue Growth
+6.31%
P/S Ratio
1.36
Revenue / Employee
$359.89K
Employees
9,500
Market Cap
3.54B GBP

Revenue Chart

* This company reports financials in USD.

Revenue by Segment

By Segment

Chart
  • Injectables 1.42B 42.5%
  • Hikma Rx 1.04B 31.0%
  • Branded 849.00M 25.4%
  • Others 40.00M 1.2%

By Geography

Chart
  • United States 1.95B 58.2%
  • Other Middle East and North Africa 529.00M 15.8%
  • Saudi Arabia 331.00M 9.9%
  • Europe and Rest of the World 270.00M 8.1%
  • Algeria 229.00M 6.8%
  • North America (Excl. United States) 26.00M 0.8%
  • United Kingdom 14.00M 0.4%
Fiscal year ended Dec 31, 2025 See the full Hikma Pharmaceuticals breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20253.35B222.00M7.10%
Dec 31, 20243.13B252.00M8.77%
Dec 31, 20232.88B358.00M14.22%
Dec 31, 20222.52B-36.00M-1.41%
Dec 31, 20212.55B212.00M9.06%
Dec 31, 20202.34B134.00M6.07%
Dec 31, 20192.21B137.00M6.62%
Dec 31, 20182.07B134.00M6.92%
Dec 31, 20171.94B-14.00M-0.72%
Dec 31, 20161.95B510.00M35.42%
Dec 31, 20151.44B-49.00M-3.29%
Dec 31, 20141.49B124.00M9.08%
Dec 31, 20131.37B256.00M23.08%
Dec 31, 20121.11B190.98M20.80%
Dec 31, 2011918.03M187.09M25.60%
Dec 31, 2010730.94M94.05M14.77%
Dec 31, 2009636.88M56.23M9.68%
Dec 31, 2008580.66M131.86M29.38%
Dec 31, 2007448.80M131.77M41.57%
Dec 31, 2006317.02M54.81M20.90%
Dec 31, 2005262.22M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.